XML 209 R79.htm IDEA: XBRL DOCUMENT v3.24.2
Long-Term Investments (Details) - Schedule of Statement of Operation - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
BioFirst [Member]        
Condensed Income Statements, Captions [Line Items]        
Net sales $ 363 $ 734 $ 30,162
Gross profit 220 289 8,239
Net loss (203,077) (406,233) (1,194,797) (1,274,539)
Share of losses from investments accounted for using the equity method (221,888)
Rgene [Member]        
Condensed Income Statements, Captions [Line Items]        
Net sales
Gross profit
Net loss (56,567) (81,842) (291,522) (1,550,123)
Share of losses from investments accounted for using the equity method